|
End-of-day quote
CBOE
|
||
| - EUR | - |
|
| 20/12/24 | Orapi SA(ENXTPA:ORAP) dropped from CAC AllShares Index | CI |
| 10/10/24 | Orapi: proposed public exchange offer filed with the AMF |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Industrial Inorganic Chemicals | ||||||||||
Specialty Chemicals | 240M | 268M | 227M | 230M | 229M | |||||
Total Assets | 193M | 227M | 185M | 191M | 184M | |||||
Interest Expense | -3.53M | -2.93M | -4.37M | -869K | -880K | |||||
Income Tax Expense | 806K | 3.54M | 717K | 267K | 90K | |||||
CAPEX | -4.34M | -5.94M | -6.84M | -8.26M | -6.24M | |||||
EBT | -2.11M | 13M | 1.11M | 1.19M | -18.26M | |||||
D&A | 18.51M | 12.29M | 11.52M | 11.09M | 12.6M | |||||
Operating Income | 1.33M | 16.13M | 7.13M | 2.86M | -16.01M | |||||
Net Income | -2.96M | 9.22M | 195K | 805K | -18.82M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Southern Europe | 216M | 245M | 206M | 207M | 210M | |||||
Total Assets | 167M | 200M | 161M | 167M | 168M | |||||
D&A | 11.46M | 11.26M | 10.55M | 10.29M | 12.05M | |||||
CAPEX | -4.04M | -5.58M | -6.57M | -8.06M | -6.03M | |||||
Operating Income | -241K | 15.14M | 6.89M | 2.49M | 1.57M | |||||
Northern Europe | 15.93M | 14.65M | 13.59M | 13.76M | 11.5M | |||||
Total Assets | 15.89M | 15.69M | 15.62M | 14.25M | 7.1M | |||||
D&A | 955K | 952K | 987K | 970K | 938K | |||||
CAPEX | -115K | -35K | -144K | -64K | -40K | |||||
Operating Income | 716K | 1.04M | -361K | -459K | -429K | |||||
Asia and The Rest of The World | 10.32M | 9.67M | 8.27M | 11.58M | 7.64M | |||||
Total Assets | 10.47M | 10.72M | 9.06M | 10.18M | 8.52M | |||||
D&A | 513K | 502K | 384K | 373K | 386K | |||||
CAPEX | -175K | -315K | -107K | -127K | -52K | |||||
Operating Income | 2.21M | 2.31M | 1.51M | 2.45M | 382K | |||||
North America | 1.71M | 1.82M | 1.74M | 1.97M | 1.9M | |||||
Total Assets | 1.5M | 1.25M | 1.48M | 1.76M | 1.6M | |||||
D&A | 97K | 96K | 100K | 106K | 99K | |||||
CAPEX | -6K | -3K | -11K | -7K | -31K | |||||
Operating Income | 140K | 168K | 113K | 124K | 107K | |||||
Elimination | -3.71M | -3.24M | -3.35M | -4.2M | -1.86M | |||||
Total Assets | -1.8M | -364K | -2.28M | -2.33M | -674K | |||||
Operating Income | 91K | -143K | 231K | -13K | 746K |
- Stock Market
- Stocks
- ORAP Stock
- 0ICI Stock
- Financials ORAPI
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















